MRNA (NASDAQ) Form 144 shows 25,770-share option exercise, prior 36,759 sale
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) reported a Form 144 notice indicating securities were sold or to be sold under Rule 144 related to a stock option exercise on 06/18/2026. The filing lists 25,770 shares tied to the June 18, 2026 exercise and a separate sale of 36,759 shares on 05/08/2026, with dollar amounts shown in the filing. The transaction method for the exercise is listed as cash and the broker-dealer noted is Fidelity Brokerage Services LLC.
Positive
- None.
Negative
- None.
Insights
Rule 144 notice for exercised/options-related sales filed, procedural disclosure only.
The filing lists a stock option exercise with 25,770 shares on 06/18/2026 and a prior sale of 36,759 shares on 05/08/2026. It names Fidelity Brokerage Services LLC as the broker-dealer and records cash as the settlement method.
These notices are routine compliance disclosures under Rule 144. The timing, beneficial ownership status, and any holding-period or volume-limit qualifiers are not shown in the excerpt; future filings or full Form 144 text would clarify whether sales were permitted under Rule 144 conditions.